A discovery by Montreal researchers is expected to improve the diagnosis and treatment of patients with myalgic encephalomyelitis (ME), better known as chronic fatigue syndrome.
But researchers from the University of Montreal and the CHU Sainte-Justine, led by Professor Alain Moreau, have found a blood biomarker that can help identify patients with ME.
To read the rest of this story, click on the link below: